Formosa Laboratories, Inc. (TPE:4746)

Market Cap	5.98B -27.0%
Revenue (ttm)	4.77B +0.7%
Net Income	339.32M -9.2%
EPS	2.79 -9.7%
Shares Out	120.26M
PE Ratio	17.81
Forward PE	n/a
Dividend	3.00 (5.94%)
Ex-Dividend Date	Aug 21, 2025

Volume	277,263
Open	49.00
Previous Close	49.70
Day's Range	49.00 - 50.20
52-Week Range	48.50 - 72.00
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 280
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4746

Financial Performance

In 2025, Formosa Laboratories's revenue was 4.85 billion, an increase of 2.54% compared to the previous year's 4.73 billion. Earnings were 441.11 million, an increase of 180.48%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error